Home

Insights

Biofil Chemicals & Pharmaceuticals Ltd P/E Ratio

Biofil Chemicals & Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

2.9 K

stocks traded

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

PE

154.9

Last updated : 12 Jun 15:30 pm

Key Highlights

    The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 154.9 as of 12 Jun 15:30 pm .a1#The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 22 on March 2019 to 121.9 on March 2023 . This represents a CAGR of 40.84% over 5 years. a1#The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 62.01 as of 12 Jun 15:05 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 11.3. The PE Ratio of Finance industry is 21.7. The PE Ratio of IT - Software industry is 28.9. The PE Ratio of Pharmaceuticals industry is 102.9. The PE Ratio of Retail industry is 142.7. The PE Ratio of Textiles industry is 7.2. In 2024a1#The Market Cap of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 10.75 crore on March 2019 to ₹ 67.42 crore on March 2023 . This represents a CAGR of 44.37% over 5 years. a1#The Revenue of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 12.32 crore to ₹ 15.61 crore over 8 quarters. This represents a CAGR of 12.56% a1#The EBITDA of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.39 crore to ₹ 0.37 crore over 8 quarters. This represents a CAGR of -2.60% a1#The Net Profit of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.21 crore to ₹ 0.25 crore over 8 quarters. This represents a CAGR of 9.11% a1#The Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1922
Mar '2010
Mar '2186.4
Mar '22134.4
Mar '23121.9

Fundamental Metrics

Market Cap

102 Cr

EPS

0.4

P/E Ratio (TTM) *

154.9

P/B Ratio (TTM) *

5.8

Day’s High

63.44

Day’s Low

61.5

DTE *

0.0

ROE *

3.9

52 Week High

78.8

52 Week Low

42.2

ROCE *

4.9

* All values are consolidated

* All values are consolidated

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

PRICE

62.01

-1.11 (-1.76%)

stock direction

Last updated : 12 Jun 15:05

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value

Market Value

103

Asset Value

22

3.6 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

0 Cr

154.9 X

PE Ratio

Market Cap

₹103.3Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

0 Cr

154.9 X

PE Ratio

Market Cap

₹103.3Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Biofil Chemicals & Pharmaceuticals Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Biofil Chemicals & Pharmaceuticals Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Biofil Chemicals & Pharmaceuticals Ltd's Share Price stands at 62.01. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-06-12T15:05:00 is 0.41. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 62.01/ 0.41= 154.85.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Biofil Chemicals & Pharmaceuticals Ltd's stock is trading at approximately 154.85 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Biofil Chemicals & Pharmaceuticals Ltd’s PE Ratio (BSE: BIOFILCHEM)

    The Price-to-Earnings (PE) ratio, used to assess Biofil Chemicals & Pharmaceuticals Ltd's stock (BSE: BIOFILCHEM), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1911
Mar '2012
Mar '21107
Mar '2294
Mar '2367

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2212
Sep '223
Dec '222
Mar '2214
Jun '232
Sep '2317
Dec '235
Mar '2316

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '220
Sep '220
Dec '220
Mar '220
Jun '230
Sep '230
Dec '230
Mar '230

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '220
Sep '220
Dec '220
Mar '220
Jun '230
Sep '230
Dec '230
Mar '230

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Biofil Chemicals & Pharmaceuticals Ltd

About Biofil Chemicals & Pharmaceuticals Ltd

    Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL. Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products.

Biofil Chemicals & Pharmaceuticals Ltd News Hub

News

Biofil Chemicals & Pharmaceuticals schedules board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

27 May 202411:24

News

Biofil Chemicals & Pharmaceuticals to declare Quarterly Result

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

31 Jan 202414:13

News

Biofil Chemicals & Pharmaceuticals to hold board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

04 Nov 202314:33

News

Biofil Chemicals & Pharmaceuticals AGM scheduled

Biofil Chemicals & Pharmaceuticals announced that the 38th Annual General Meeting (AGM) of...

Read more

26 Aug 202312:52

News

Biofil Chemicals & Pharmaceuticals to announce Quarterly Result

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

08 Aug 202312:59

News

Biofil Chemicals & Pharmaceuticals to declare Quarterly Result

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

27 May 202316:30

Product Composition by Percentage (Revenue)

FAQs for PE of Biofil Chemicals & Pharmaceuticals Ltd

What is Biofil Chemicals & Pharmaceuticals Ltd current share price?

The current market price of Biofil Chemicals & Pharmaceuticals Ltd as of June 12, 2024 is ₹62.01.

What is Biofil Chemicals & Pharmaceuticals Ltd's market cap?

Biofil Chemicals & Pharmaceuticals Ltd's market capitalisation stood at ₹103 Cr as of June 12, 2024

What are Biofil Chemicals & Pharmaceuticals Ltd's total net assets?

According to Biofil Chemicals & Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹22.4 Cr.

Is Biofil Chemicals & Pharmaceuticals Ltd making a profit or loss?

Biofil Chemicals & Pharmaceuticals Ltd's net Profit as of June 12, 2024 is close to ₹0 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199